Form 8-K - Current report:
SEC Accession No. 0001193125-17-013610
Filing Date
2017-01-20
Accepted
2017-01-20 06:31:32
Documents
4
Period of Report
2017-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d332641d8k.htm 8-K 30475
2 EX-10.1 d332641dex101.htm EX-10.1 38497
3 EX-99.1 d332641dex991.htm EX-99.1 10111
4 GRAPHIC g332641g0119123817114.jpg GRAPHIC 5152
  Complete submission text file 0001193125-17-013610.txt   87822
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 17537491
SIC: 2834 Pharmaceutical Preparations